ANO31905 in Combination With Chemotherapy for CLDN18.2-Positive Locally Advanced Unresectable or Metastatic Pancreatic Cancer
Anova Innovation Limited
Anova Innovation Limited
Evopoint Biosciences Inc.
BigHat Biosciences, Inc.
Bristol-Myers Squibb
Beijing Biotech
Lumos Pharma
Verastem, Inc.
EMD Serono
Revolution Medicines, Inc.
Recurv Pharma Inc
iOnctura
Erasca, Inc.
Frontier Medicines Corporation
Beijing Biotech
Filamon LTD
AstraZeneca
NeoImmuneTech
Engeneic Pty Limited
Lokon Pharma AB
Intima Bioscience, Inc.
Amplia Therapeutics Limited
A2 Biotherapeutics Inc.
AstraZeneca
Arvinas Inc.
Tasca Therapeutics
MBrace Therapeutics
Xerient Pharma
Revolution Medicines, Inc.
Auricula Biosciences Inc.
Bold Therapeutics, Inc.
Takeda
Jacobio Pharmaceuticals Co., Ltd.
Lumicell, Inc.
Jacobio Pharmaceuticals Co., Ltd.
Second Life Therapeutics
Nuvation Bio Inc.
Ascentage Pharma Group Inc.
Suzhou Transcenta Therapeutics Co., Ltd.
Medigen Biotechnology Corporation
Tyligand Pharmaceuticals (Suzhou) Limited
VM Oncology, LLC
Sotio Biotech Inc.
Revolution Medicines, Inc.
Alaunos Therapeutics
BioNTech SE
Incyte Corporation
Bristol-Myers Squibb
Alligator Bioscience AB
Ability Pharmaceuticals SL
Mirati Therapeutics Inc.